Status:
COMPLETED
Investigate the Aerosol Particle Distribution During Aerosol Generating Procedures
Lead Sponsor:
Rush University Medical Center
Conditions:
Transmission, Patient Professional
High-flow Nasal Cannula
Eligibility:
All Genders
18+ years
Brief Summary
Massive number of clinicians were infected during the outbreak of COVID-19, which raised the concerns of utilizing "aerosol generating procedures", particularly the use of high-flow nasal cannula, non...
Detailed Description
The intent is to monitor exhaled aerosol produced by COVID-19 patients pre and post aerosol generating procedures. Monitoring will occur at a distance of 1 and 3 feet from the subject's airway. This o...
Eligibility Criteria
Inclusion
- • Adult patients who are diagnosed as COVID-19 infection in ICU or Adult patients are indicated for pulmonary function tests
Exclusion
- • No need for any respiratory therapy
Key Trial Info
Start Date :
May 20 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 30 2020
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT04353531
Start Date
May 20 2020
End Date
August 30 2020
Last Update
April 23 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rush university medical center
Chicago, Illinois, United States, 60612